Skip to main content
Log in

ASO Visual Abstract: Drug-Eluting Beads with Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin

  • ASO Visual Abstract
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Acknowledgment

The study was sponsored by RCGM and the University of Louisville School of Medicine. Funding for the study was provided by the University of Louisville, Division of Surgical Oncology (FDA: IDE Submission No. NCT01648023). Partial funding for this study came from both BTG/Biocompatibles and Boston Scientific. The authors extend a special thanks to all the patients and research coordinators who put their heart and soul into this trial and completion.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Robert C. G. Martin II MD, PhD, FACS.

Ethics declarations

Disclosures

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Martin, R.C.G., Simo, K.A., Hansen, P. et al. ASO Visual Abstract: Drug-Eluting Beads with Irinotecan Therapy of Unresectable Intrahepatic Cholangiocarcinoma (DELTIC) with Concomitant Systemic Gemcitabine and Cisplatin. Ann Surg Oncol 29, 5474–5475 (2022). https://doi.org/10.1245/s10434-022-12022-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-022-12022-0

Navigation